Sign Out
Clinical Experience: DUOLAC Derma was studied in 64 subjects with mild to moderate AD. Subjects received either multispecies probiotics (Lactobacillus rhamnosus, Lactobacillus plantarum, Lactobacillus casei, and Bifidobacterium animalis subsp. lactis) or a placebo for a period of 8 weeks. After 8-weeks with probiotics, the EASI score was significantly improved, 50% of the subjects experienced improvement of their skin conditions.
DUOLAC Derma was studied in 100 children with mild to moderate AD by randomized, double-blind, placebo-controlled, parallel trial with a washout period of 2 weeks and an intervention period for 6 weeks.
The probiotic significantly improved their skin conditions.
